Medipharm Labs Corp banner

Medipharm Labs Corp
OTC:MEDIF

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
OTC:MEDIF
Watchlist
Price: 0.0549 USD 2.62% Market Closed
Market Cap: $22.2m

Relative Value

MEDIF doesn't have a meaningful market cap.

The Relative Value of one MEDIF stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.0549 USD, Medipharm Labs Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDIF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

MEDIF Competitors Multiples
Medipharm Labs Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Medipharm Labs Corp
OTC:MEDIF
31.6m USD 0.7 -3.9 -2.6 -2.1
US
Eli Lilly and Co
NYSE:LLY
952.4B USD 14.6 46.1 31.1 33.2
US
Johnson & Johnson
NYSE:JNJ
592.2B USD 6.3 22.1 15.3 18.8
CH
Roche Holding AG
SIX:ROG
282.2B CHF 4.6 30.3 12.8 14.9
CH
Novartis AG
SIX:NOVN
242.7B CHF 5.6 22.4 13.8 17.8
UK
AstraZeneca PLC
LSE:AZN
232.5B GBP 5.3 30.6 16.9 23.8
US
Merck & Co Inc
NYSE:MRK
298.8B USD 4.6 16.4 10.1 12.4
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 10.8 8 9.4
US
Pfizer Inc
NYSE:PFE
151.6B USD 2.4 19.5 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD 2.6 17.8 7.4 9.2
P/E Multiple
Earnings Growth PEG
CA
Medipharm Labs Corp
OTC:MEDIF
Average P/E: 24
Negative Multiple: -3.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.1
28%
1.6
US
Johnson & Johnson
NYSE:JNJ
22.1
7%
3.2
CH
Roche Holding AG
SIX:ROG
30.3
29%
1
CH
Novartis AG
SIX:NOVN
22.4
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
30.6
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16.4
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
7%
1.5
US
Pfizer Inc
NYSE:PFE
19.5
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.8
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Medipharm Labs Corp
OTC:MEDIF
Average EV/EBITDA: 46.8
Negative Multiple: -2.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.1
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.3
2%
7.7
CH
Roche Holding AG
SIX:ROG
12.8
5%
2.6
CH
Novartis AG
SIX:NOVN
13.8
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
16.9
13%
1.3
US
Merck & Co Inc
NYSE:MRK
10.1
3%
3.4
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8
2%
4
US
Pfizer Inc
NYSE:PFE
7.5
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Medipharm Labs Corp
OTC:MEDIF
Average EV/EBIT: 101.5
Negative Multiple: -2.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.2
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
18.8
7%
2.7
CH
Roche Holding AG
SIX:ROG
14.9
6%
2.5
CH
Novartis AG
SIX:NOVN
17.8
9%
2
UK
AstraZeneca PLC
LSE:AZN
23.8
21%
1.1
US
Merck & Co Inc
NYSE:MRK
12.4
6%
2.1
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.4
3%
3.1
US
Pfizer Inc
NYSE:PFE
10
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
9.2
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett